Biophytis SA, 2026-03-23
An SEC Form D private-offering notice from Paris, a $1,584,275 filer-stated offering target in Biotech. Filed 2026-03-23. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Clinical-stage biotechnology company developing BIO101, a drug candidate for age-related diseases including sarcopenia and obesity, listed on Nasdaq and Euronext Growth Paris.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- AFFINITY BIOSENSORS LLC, 2026-03-23, $10M, Santa Barbara, CA
- Conexeu Sciences Inc., 2026-03-23, $45K, Reno, NV
- Vira Regen Inc., 2026-03-23, $3M, Salt Lake City, UT
- Atommap Corp, 2026-03-20, $59.6M, New York, NY
- Consano Bio, Inc., 2026-03-20, $48.9M, Burlington, MA
- Jitai Biological Technology Ltd, 2026-03-19, $5M, Hong Kong
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.